Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Chaffin Luhana Expands Its Leadership In The Zantac MDL
  • USA - English

Chaffin Luhana LLP, a national plaintiffs-only law firm, is pleased to announce that Associate Kendra Goldhirsch was recently appointed by U.S. District Judge Robin L. Rosenberg to the Plaintiffs' Leadership Development Committee (LDC) in the In re: Zantac (Ranitidine) Products Liability Litigation (MDL No. 2924).


News provided by

Chaffin Luhana LLP

Mar 15, 2022, 08:00 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, March 15, 2022 /PRNewswire-PRWeb/ -- Ms. Goldhirsch is one of what the court called a "new slate" of LDC members, each of whom has played an important role on the plaintiffs' leadership team in prosecuting the multidistrict litigation (MDL). The court expressed its opinion that this next generation of MDL leaders "will be well suited to assume even greater leadership roles in future MDLs."

Ms. Goldhirsch is continuing the firm's efforts on the forefront of the Zantac litigation. She joins Partner, Roopal Luhana, who was appointed as the Chair of the ESI/Document Production Committee at the inception of the Plaintiff's Steering Committee (PSC) in May 2020.

"We are so proud of Kendra being appointed to the LDC for the Zantac litigation. She goes above and beyond not only for our clients but all plaintiffs who have suffered due to negligent actions by these drug manufacturers," says Partner, Roopal Luhana.

The court interviewed over 60 applicants in May 2020 in preparation for the initial appointments. Judge Rosenberg noted in the pretrial order that the court was impressed by the insights of each of these applicants. The court considered many factors before making its selections, including an applicant's skill, background, ethical standards, professionalism, collaboration, other leadership positions, and reputation earned from colleagues and judges in other litigations.

The court also sought to "appoint a diverse leadership team that is representative of the inevitable diversity of the plaintiffs and a team that affords younger and slightly less experienced attorneys an opportunity to participate in a leadership role in an MDL."

"We continue to support our attorneys in obtaining unique opportunities to lead national litigations and grow their skills. Kendra will continue to do a stellar job in an important litigation for our clients. And we are proud that two of our attorneys have been appointed by the court," says Managing Partner, Eric Chaffin.

Ms. Goldhirsch has worked extensively on the Zantac MDL since its inception and has been involved in the day-to-day management of the firm's Zantac cases on behalf of clients who suffer from cancer due to their alleged Zantac use. Ms. Goldhirsch has worked on extensively on MDLs during her career, including the In re: Sorin 3T Heater-Cooler System Products Liability Litigation, working on a broad range of matters including ESI and discovery, depositions, briefing, and with experts.

Ms. Goldhirsch has been a member of several trial teams in pharmaceutical bellwether cases that were tried to verdict in state and federal courts. She was a member of the Actos Multidistrict Litigation trial team that secured a multibillion-dollar verdict. (See Allen, et al. v. Takeda Pharmaceutical Co. Ltd. et al., Case No. 6:12-cv-00064). She has also briefed successful dispositive and evidentiary motions and oppositions addressing a variety of topics including, jurisdiction, removal and remand, forum non-conveniens, complex expert and regulatory matters, drug labeling, and federal preemption. 

On April 1, 2020, the U.S. Food and Drug Administration (FDA) requested the removal of all Zantac and generic ranitidine products from the market due to the potential for contamination with N-nitrosodimethylamine (NDMA), a cancer-causing agent. The FDA first warned of the presence of NDMA in Zantac back in September 2019 and suggested all manufacturers test their products for the impurity. Later, investigators discovered that the level of NDMA in Zantac could increase over time and when exposed to higher temperatures, such as those that occur during shipping and storage. Several companies had already recalled their medications before the April FDA request, and now all ranitidine products have been removed from the market.

Plaintiffs filing lawsuits against Zantac manufacturers argue that the defendants were aware of the risks associated with ranitidine for decades yet concealed these risks from healthcare providers and the general public.

About Chaffin Luhana:
Chaffin Luhana LLP is a plaintiffs-only national trial firm focused on representing injured survivors and their families in catastrophic and complex cases. Started by former federal prosecutors Eric Chaffin and Roopal Luhana, the firm is comprised of former state and federal prosecutors, former large defense firm attorneys, former judicial law clerks, and caring and compassionate staff including an in-house social worker. The firm has been appointed by federal and state courts to important national litigations including the 3T Heater-Cooler Litigation, the Transvaginal Mesh Litigation, the Yaz Birth Control Litigation, and the Denture Cream Zinc Poisoning Litigation, among others. Notably, Ms. Luhana was recently appointed to the Plaintiffs' Steering Committee (PSC) in the Zantac (Ranitidine) Products Liability Litigation (S.D.FL.). With over 130 years of combined legal experience, Chaffin Luhana's attorneys have recovered over $1 billion for their clients nationwide.

If you or a loved one has suffered an injury or death due to an accident, dangerous medication, defective medical device, or faulty product, contact Chaffin Luhana LLP for a free and confidential case review at 888-480-1123 or visit their website at https://www.chaffinluhana.com/.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Media Contact

Dan Reo, Chaffin Luhana LLP, +1 (888) 480-1123, [email protected]

SOURCE Chaffin Luhana LLP

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.